INFORMED CONSENT IN GENETIC REASEARCH

  • Ljupco Chakar Institute of Forensic Medicine and Criminology, Faculty of Medicine, Ss Cyril and Methodius University in Skopje, North Macedonia
  • Aleksandar Stankov Institute of Forensic Medicine and Criminology, Faculty of Medicine, Ss Cyril and Methodius University in Skopje, North Macedonia
  • Goran Pavlovski Institute of Forensic Medicine and Criminology, Faculty of Medicine, Ss Cyril and Methodius University in Skopje, North Macedonia
  • Natasha Bitoljanu Institute of Forensic Medicine and Criminology, Faculty of Medicine, Ss Cyril and Methodius University in Skopje, North Macedonia
  • Viktorija Belakaposka Srpanova Institute of Forensic Medicine and Criminology, Faculty of Medicine, Ss Cyril and Methodius University in Skopje, North Macedonia
  • Ana Ivcheva Institute of Forensic Medicine and Criminology, Faculty of Medicine, Ss Cyril and Methodius University in Skopje, North Macedonia
  • Rosica Siamkouri Institute of Forensic Medicine and Criminology, Faculty of Medicine, Ss Cyril and Methodius University in Skopje, North Macedonia
  • Zlatko Jakjovski Institute of Forensic Medicine and Criminology, Faculty of Medicine, Ss Cyril and Methodius University in Skopje, North Macedonia

Abstract

Recognizing the ethical, legal, and social implications (ELSI) of genetic testing becomes crucial for physicians in the face of complex medical issues, as they are increasingly expected to counsel their patients regarding the medical, psychological, and social responses arising from genetic information. Genetic medicine, with its extreme complexity and the potential repercussions on an individual's life, raises important questions in the ethical, deontological, and legal realms of medicine, playing a primary role in personalized medicine. The aim of this paper is to underscore the significance of informed consent and to provide insights into the ethical procedures associated with genetic testing.


Keywords: informed consent, genetic, genomic testing, ELSI


 

References

1. G. Geller, JR Botkin, MJ Green et al. Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent. Journal of American Medical Association. 1996; 277:1467- 1474.
2. EV Lapham, C Kozma, JO Weiss. Genetic discrimination: Perspectives of consumers. Science. 1996; 274: 621-624.
3. U.S Congress, Office of Technology Assessment . Genetic Counseling and Cystic Fibrosis Carrier Screening . Washington, DC: U.S. Government Printing Office. 1992; Results of Survey –Background Paper, OT-BP – BA -97.
4. BP Fuller, MJE Kahan, PA Barr, L Biesecker et al. Privacy in genetic research.Science.1999; 285:1359-1361
5. MA Hall, SS Rich. Laws restricting health insurers use of genetic information: Impact on genetic discrimination. American Journal of Human Genetics. 2000; 66: 293-307.
6. Mefhan B. Bioethics, an introduction for the biosciences, Oxford University Press 2005;3-227, ISBN 0-19-926715-4 978-0-19-926715-6.
7. National Commission for the Protectionof Human Subjects of Biomedical and behavioral Research (NCPHS).1979. Belmont report: Ethical princips and guidelines for the protection of human subjects of research. Federal Register 44.US Department of Health and Human Services. Protection of human subjects.45.C.F.R. part 46. [Google Scholar].
8. OHRP&DHHS 2018. Code of federal regulations – Title 45:Public welfare and title 46. Protection of Human Subjects.45 CFR 46 1-14. [Google Scholar].
9. P.Bin, A Conti, E, Capasso et al. Genetic testing: Ethical aspects. 2018; Open Med.(Wars);13:247-252. Doi.10.1515.med-2018-0038.
10. Joseph G, Pasick RJ, Schillinger D, et al. Erratum to: Information Mismatch: Cancer Risk Counseling with Diverse Underserved Patients. J. Genet.Couns.2017; 26:1090-1104.Eratum in J.Genet.Couns 2017;26: 1105. [CrossRef].
11.Beauchamp TL. Informed consent: its history, meaning, and present chalanges. Comb Q Healthc Ethics 2011; 20: 515-523 10.1017/SO963180111000259 [PubMed] [CrossRef] [Google Scholar]
12. World Medical Association. World Medical Assocciation Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA.2013:310:2191 – 4 [PubMed] [Google Scholar]
13. Ormond KE, Wheeler MT, Hudgins I, Klein TE, et al Chalanges in the clinical app;ication of whole-genome sequencing. Lancet 375: 1749-1751.10.106/S0140-6736(10)60599-5 [PubMed] [CrossREf] [Google Scholar]
14. Mardis FR. A decades perspective in DNA sequencing technology. Neture 2011; 470(7333):198-203.doi:10.1038/nature09796.
15. Shendure J Aiden EL: The expanding scope of DNA sequencing. Native Biotechnology 2012,30(11):1084-1094. Doi: 10.1038/nbt.2421
16. Caulfield T. McGuire AL, Cho M, Buchanan JA et al. Research ethics recommendations for whole - genome research: consensus statement. PLoS Biology 2008;693).doi.10.1371/journal.pbio.0060073.
17. McGuire AL, Caulfield T, Cho MR: Research ethics and challenge of whole-genome sequencing. Nat Rev Genet. 2008; 9(2):152-156 doi: 10.1038/nrg 2302
18. Kaye J, Boddington P, de Vries J, Hawkins N et al. Ethical implications of the use of the whole genome sequencing in medical research. Eur J of Hum Genet, 2010; 18(4): 398-403 doi:10.1038/ejhg.2009.191
19. Tabor HK, Berkman BE, Hull SC, Bamshad MJ. Genomics really gets personal: how exome and whole genome sequencing challenge the ethical framework of human genetics research. Am J of Med Genet. A. 2011; 155A (12):2916-2924.doi:10.102/ajm.a.34357
20. Patch C, Middleton A. Genetic counselling in the era of genomic medicine. Br Med Bull.2018; 126: 27-36.10.1093/bmb/Idy008 [PubMed] [CrossREf] [Google Scholar].
21. Williams J, Faucett W, Smith- Packard et al. An assessment of time involved in pretest cas e review and counseling for a whole genome sequencing clinical research program. J Genet Couns 2014; 23:516-521.10.007/s 10897-014-9697-4 [PubMed] [CrossREf] [Google Scholar]
22. Samuel GN, Dheensa S, Farsides B, et al. Healthcare professionals and patients perspectives on consent to clinical genetic testing:moving towards a more relational approach. BMC Med Ethics 2017; 18:47 10.1186/s12910-017-0207-8 [PubMed] [CrossREf] [Google Scholar]
23. Bunnik EM, de Jong A, Nijsingh N, de Wert GMWR, 2013a.The new genetics and informed consent:differentiating choise to preserve autonomy. Bioethics 2013;27(6):348-355.101111/bioe.12030. PMID: 23718722
24. Klima J, Fitzgerald- Butt SM, Kelleher KJ, Chisolm DJ et al. Understending of informet consent by parents of children enrolled in a genetic biobank. Genet Med 2014; 16 (2): 141-48.doi: 10.1038/gim.201386 Epub 2013 jun 27. PMID: 23807615
25. Kaye J, Boddington P, Vries J, Hawkins N et al. Ethical implications of the use of whole genome methods research. Eur J of Hum Genet 2010; 18(4):398-403. Doi:10.1038/ejhg.2009.191. Epub 2009 Nov 4,PMID:19888293; PMCID: PMC2879322
26. Worthey EA, Mayer AN, Syverson GD, Helbling D et al Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med 2011;13(3):255-62.doi:10.1097/GIM.ObO133182088158.PMID:21173700.
27. Bainbridge MN, Wiszniewski W, Murdock DR, et al. Whole-genome sequencing for optimized patient management. Sci Transl Med.2011; 15:3(87):87re3.doi:10.1126/scitranslmed 3002243.PMID: 21677200; PMCID: PMC3314311.
28. Gonzaga Jauregui C, Lupski JR, Gibbs RA, et al. Human genome sequencing in health and disease. Annu Rev Genet 2012; 63:35-61.doi;10.1146/annurev-med-051010-162644.PMID:22248320; PMCID:PMC3656720.
29. Biesecker LG, Burke W, Kohane I, et al. Next –generation sequencing in the clinic: are we are ready? Nat Rev Genet. 2012; 13(11):811-24.doi:10.1038/nrg3357. PMID:23076269; PMCID:PMC3891793.
Published
2023-12-27
How to Cite
CHAKAR, Ljupco et al. INFORMED CONSENT IN GENETIC REASEARCH. Journal of Morphological Sciences, [S.l.], v. 6, n. 3, p. 129-134, dec. 2023. ISSN 2545-4706. Available at: <https://jms.mk/jms/article/view/vol6no3-16>. Date accessed: 22 oct. 2024.
Citation Formats
Issue
Vol 6 No 3 (2023): JMS
Section
Articles